focus -WSS

focus

author：Wikipedia 2025-10-01 20:15:46 - browse：3972

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biogen Alzheimer’s drug launch off to slow start

Wikipedia

WSS

Medicare Advantage proposed rates disappoint insurers

Private equity deals in Medicare Advantage declines

What should King Charles tell the public about his cancer?

Lack of darker skin in textbooks, journals harms patients of color

The Readout: Gilead, Bernie Sanders, and other pharma news

Key House Republican on health care plans exit from Congress

focus

focus

focus

In Memoriam: Notable people who died in 2023

To avoid data mishandling cases, universities eye AI and other tools

Medicare proposal to cover medical devices draws a mixed reaction

Study: Hearing aids may slow cognitive decline in those at risk

Virginia high school admissions case could be legal follow

Johnson & Johnson sues to stop Medicare negotiation

The high cost of giving birth even with insurance

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

State Dept. review finds Biden bears some blame for Afghanistan failures

A look at other Americans who have crossed into North Korea over the years

entertainment

Key House Republican on health care plans exit from Congress

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

House passes resolution saying Israel isn't a 'racist or apartheid state'

Medicare threatens to cut off funding for HCA's Mission hospital

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

More hospitals are billing patients as online messages surge

leisure time

leisure time

Wikipedia

focus